Sumitomo Mitsui Trust Group’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
9,218,455
-346,876
| -4% | -$430K | 0.01% | 664 |
|
|
2025
Q1 | $11.3M | Sell |
9,565,331
-613,170
| -6% | -$724K | 0.01% | 682 |
|
|
2024
Q4 | $18.6M | Sell |
10,178,501
-1,687,265
| -14% | -$3.09M | 0.01% | 654 |
|
|
2024
Q3 | $20.2M | Sell |
11,865,766
-774,795
| -6% | -$1.32M | 0.01% | 635 |
|
|
2024
Q2 | $17.3M | Sell |
12,640,561
-183,824
| -1% | -$252K | 0.01% | 658 |
|
|
2024
Q1 | $48.1M | Sell |
12,824,385
-375,990
| -3% | -$1.41M | 0.03% | 505 |
|
|
2023
Q4 | $129M | Sell |
13,200,375
-247,291
| -2% | -$2.43M | 0.1% | 218 |
|
|
2023
Q3 | $112M | Sell |
13,447,666
-202,282
| -1% | -$1.69M | 0.09% | 226 |
|
|
2023
Q2 | $182M | Sell |
13,649,948
-356,567
| -3% | -$4.74M | 0.14% | 152 |
|
|
2023
Q1 | $162M | Sell |
14,006,515
-159,678
| -1% | -$1.85M | 0.12% | 178 |
|
|
2022
Q4 | $116M | Sell |
14,166,193
-225,769
| -2% | -$1.85M | 0.09% | 252 |
|
|
2022
Q3 | $83.5M | Buy |
14,391,962
+46,477
| +0.3% | +$270K | 0.07% | 332 |
|
|
2022
Q2 | $63.4M | Buy |
14,345,485
+324,280
| +2% | +$1.43M | 0.05% | 421 |
|
|
2022
Q1 | $128M | Buy |
14,021,205
+2,106,180
| +18% | +$19.2M | 0.09% | 260 |
|
|
2021
Q4 | $244M | Buy |
11,915,025
+2,567,023
| +27% | +$52.5M | 0.15% | 149 |
|
|
2021
Q3 | $239M | Buy |
9,348,002
+1,215,677
| +15% | +$31.1M | 0.15% | 143 |
|
|
2021
Q2 | $284M | Buy |
8,132,325
+2,929,012
| +56% | +$102M | 0.17% | 136 |
|
|
2021
Q1 | $173M | Buy |
5,203,313
+725,219
| +16% | +$24.2M | 0.11% | 207 |
|
|
2020
Q4 | $116M | Buy |
4,478,094
+361,541
| +9% | +$9.38M | 0.08% | 299 |
|
|
2020
Q3 | $40.6M | Buy |
+4,116,553
| New | +$40.6M | 0.03% | 548 |
|